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Abstract A new member of the dystrobrevin gene family was
identified using a bioinformatics approach. Sequence analysis
indicates that this gene, named DTN-B, is highly homologous to
the rabbit A0, the previously described dystrobrevin (DTN),
Torpedo 87 kDa and to the C-terminus of dystrophin. The coiled-
coil domain, shown to be the site of interaction between
dystrobrevins and dystrophin, is highly conserved. Immunostain-
ing studies indicate that DTN-B and DTN expression is absent in
affected muscle fibers from DMD patients and carriers.
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1. Introduction
Dystrophin, the protein product of the Duchenne muscular
dystrophy (DMD) gene, is a membrane associated protein
localized to the cytoplasmic surface of the muscle membrane.
Although this gene has been shown to be defective in DMD
patients, the pathogenetic mechanisms of the progressive mus-
cular wasting are not yet completely understood. A number of
membrane associated proteins have been described in mam-
mals to interact with dystrophin. These proteins are known as
the dystrophin associated proteins (DAPs) [1]. The DAP com-
plex is composed of three di¡erent groups: the dystroglycan
(K and L), the sarcoglycan (K, L, Q and N), and the cytoplasmic
(syntrophin and dystrobrevin) subcomplexes; for a review see
[2,3].
Biochemical studies have shown that the DAP complex is
conserved in various organisms including Torpedo californica.
When dystrophin is puri¢ed from Torpedo, it is found in as-
sociation with two proteins of 58 kDa and 87 kDa [4,5]. The
87 kDa protein shows some homology to the dystrophin
COOH-terminal region, which contains a syntrophin binding
site [6,7] and a coiled-coil domain [8].
A0 is a 94 kDa protein puri¢ed from rabbit skeletal muscle
[1]. A monoclonal antibody (MA0) raised by immunization of
mice with a puri¢ed DAP complex was shown to react with
A0 and to recognize a 62 kDa and a 94 kDa band [9]. A
partial cDNA corresponding to the rabbit A0 protein was
sequenced, and based on the sequence homologies and on
the similarity in molecular weight, the authors concluded
that A0 is the rabbit homolog of the Torpedo 87 kDa [9].
Dystrobrevins (DTN) are dystrophin related proteins re-
cently identi¢ed in both humans and mice [10,11]. DTN en-
codes proteins of various sizes (DTN-1, DTN-2 and DTN-3),
which are predominantly expressed in brain, skeletal and car-
diac muscle and are highly homologous to dystrophin, partic-
ularly in the C-terminus where two heptad leucine repeats are
located. These leucines, predicted to form coiled-coils, have
been recently demonstrated to interact with dystrophin [12] as
previously postulated [13]. Sequence homologies and bio-
chemical studies led the authors to conclude that dystrobre-
vins represent the homolog of the rabbit A0 and Torpedo 87
kDA proteins [10,11].
Using a bioinformatics approach, we have identi¢ed a novel
member of the cytoplasmic group of dystrophin related pro-
teins. This new gene is homologous but not identical to the
previously reported dystrobrevins. We thus named it dystro-
brevin B (DTN-B). Sequence analysis reveals that DTN-B is
more closely related to the partial rabbit A0 sequence than the
previously reported dystrobrevins.
The coiled-coil domain in the C-terminus is highly con-
served in DTN-B, implying that this region could also be
the interaction site of DTN-B and dystrophin.
2. Materials and methods
2.1. cDNA library screening
Teratocarcinoma/neuron (mature hNT neuron, Stratagene 937233)
and skeletal muscle (Clontech) human cDNA libraries were used to
characterize the human full-length cDNA. A mouse embryo cDNA
library (Clontech) was screened in order to obtain the murine full-
length cDNA. Plating hybridization and washing conditions were as
previously described [14]
2.2. cDNA sequence analysis
cDNA sequence analysis and nucleotide and protein database
searches were performed as previously described [15]. Data on sim-
ilarity/identity were obtained using the Best¢t program of the GCG
software package, Version 8.1. The multiple alignment analyses were
generated using the PileUp program of the Wisconsin GCG software
package, Version 8.1.
2.3. Expression studies
For Northern blot analysis, commercial Northern blots (Clontech)
were used according to the manufacturer’s recommendation.
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2.4. RACE
3P-RACE was performed from 1 Wg of total RNA from human
skeletal muscle. Reverse transcriptase (BRL) was from the semi-ran-
dom oligo 5P-NNNNNNSS-3P. Nested ampli¢cations were performed
with speci¢c forward primers TO2865 (1190^1213 bp) and VR2
(1634^1656 bp) of the DTN-B2 sequence, together with standard
RACE primers. PCR conditions are reported below.
2.5. PCR conditions
PCR ampli¢cations were performed as previously described [16]
using the following forward primers: 640F (694^719 bp), TO2864
(962^985 bp), TO4094 (1743^1764 bp), VRCF (1855^1877 bp),
RH5P (1975^1994 bp), EX20A (1715^1735 bp), TO3342 (1530^1549
bp) of the DTN-B1 sequence, and reverse primers: VRBR (1764^1743
bp), VRCR (1876^1854 bp), TO8080 (1903^1884 bp), RH3P (2187^
2169 bp), 3PUTRB (1991^1968 bp), 1225R (1315^1290 bp) of the
DTN-B1 sequence, VR2 3PUTR (1683^1663 bp) of the DTN-B2 se-
quence, and A54R (1456^1436 bp) of mDTN-B sequence. PCR con-
ditions were: 30^35 cycles with denaturation at 96‡C (30 s), annealing
at 55^60‡C (1 min) and extension at 68‡C (2^8 min).
2.6. FISH, YAC and RH mapping
FISH, YAC and RH mapping were performed as previously de-
scribed [16]
2.7. Immunoblot analysis of fusion proteins and muscle tissue
GST fusion proteins and homogenate from human muscular tissue
were prepared as previously described [16]. Samples were run on 11%
SDS-PAGE [17] and transferred to nitrocellulose sheets [18]. Mem-
branes were incubated for 2 h at room temperature with MA0 anti-
body (0.25 mg/ml diluted 1:500 in PBS with 3% non-fat milk, 0.05%
Tween 20 and 0.05% NP40), washed and incubated 1h with peroxi-
dase conjugated anti mouse IgG (diluted 1:10 000 in PBS with 0.5%
non-fat milk, 0.05% Tween 20 and 0.05% NP40). Immunoreactive
bands were visualized by ECL according to the speci¢cations of the
manufacturer (Amersham).
2.8. Immunohistochemistry
Skeletal muscle biopsy specimens were from normal controls, DMD
carriers and a¡ected patients. Immunostaining was performed with
the streptavidin-biotin peroxidase method (YLEM kit, Italy). Endog-
enous peroxidase was blocked with hydrogen peroxide 0.3% in abso-
lute methanol for 30 min. After rinsing with PBS, sections were in-
cubated for 30 min with normal serum. The primary antibodies were
diluted (MA0 0.25 mg/ml 1:200 and the monoclonal antibody speci¢c
for dystrophin C-terminus, YLEM, 1:50) in PBS containing 0.5%
BSA. Biotinylated anti-mouse immunoglobulins (YLEM kit) were
used as a secondary antibody. After washing in PBS, the sections
were incubated in streptavidin conjugated to horseradish peroxidase.
As a negative control, the primary antibody was omitted in every set
of staining. In all cases, serial sections were stained with routine his-
tochemistry (PAS, Gomori, NADH, etc.).
3. Results
3.1. Identi¢cation and characterization of the human and
murine DTN-B cDNAs
The sequence corresponding to the Torpedo 87 kDa protein
(GenBank accession no. L06945) was used as a query to
search the dbEST database using the BLAST-N algorithm.
Several ESTs were identi¢ed. Sequence analysis revealed
that some of them corresponded to di¡erent isoforms of the
recently described DTN [10] and were excluded from the
present study. A number of human ESTs revealed to be highly
homologous but not identical, suggesting the existence of a
di¡erent gene which we named dystrobrevin B (DTN-B).
These ESTs were further characterized. The IMAGE clone
48908 derived from a human infant brain cDNA library
(EST H14817) was entirely sequenced. Analysis of the con-
sensus sequence (2247 bp, GenBank accession number
Y12712) revealed the presence of a putative initiation codon
at position 184 and a stop codon (TAG) at nucleotide 1885,
thus indicating that this clone corresponds to the full-length
cDNA sequence. The coding region spans 1701 bp resulting in
a predicted protein of 567 amino acids, with a predicted mo-
lecular weight of 64 kDa.
Using the sequence corresponding to human DTN-B, two
non-overlapping mouse ESTs (AA036262 and AA545996, de-
rived from a mouse embryo and a mouse T cell cDNA library,
respectively) were identi¢ed and sequenced. Oligonucleotides
(TO2864 and AA54R) were used to amplify cDNA from a
mouse embryo at embryonic day 13.5. The PCR product was
sequenced and assembled with the sequences already avail-
able. This e¡ort allowed us to assemble a 2192 bp partial
murine cDNA (GenBank accession number Y15742). Se-
quence analysis revealed a start codon at position 93, which
is conserved in the human counterpart, and an open reading
frame of 2102 bp, which is still open at the 3P end. RT-PCR
and screening of cDNA libraries failed to identify a mouse
cDNA clone containing the stop codon. Sequence comparison
of the mouse and human sequences revealed that the two
genes are highly homologous (90.6% identity at the nucleotide
level, and 94.9% identity and 95.7% similarity at the protein
level), indicating that mDTN-B represents the bona ¢de mur-
ine homolog of DTN-B. Sequence analysis shows that the
murine counterpart does not contain a 90 bp stretch present
in the human sequence (position 1829^1919 of the Y12712
sequence) that includes the stop codon, suggesting that the
murine gene encodes a protein larger than what was found
in human.
3.2. Characterization of di¡erent splice forms for human
DTN-B
We undertook an extensive study of all available EST
clones together with RT-PCR and 3P RACE experiments on
cDNA from skeletal muscle using the oligonucleotides de-
scribed in Section 2 and in Fig. 1A.
RT-PCR with oligo 640F and 1225R gave an ampli¢cation
product larger than expected. Sequence analysis of this PCR
product showed the presence of an additional 90 bp at posi-
tion 1262. This region was designated site variable region A
(VRA, GenBank accession number Y15720) and corresponds
to the VR3 described in the mouse dystrobrevin [11]. RT-PCR
with oligo EX 20A and 3P UTRB gave three di¡erent ampli-
¢cation products of 278, 224 and 188 bp. Sequence analysis of
these products revealed the presence of 90 additional bp in the
224 bp product (VRB, GenBank accession number Y15719) at
position 1829 and the absence of 54 bp (VRC) in the same
position. The PCR product of 188 bp was identical to the
sequence from clone 48908, which included VRC, while the
fragment of 278 bp contained VRB and VRC. RT-PCR data
were con¢rmed by the existence in the dbEST database of
human cDNA clones containing the three di¡erent regions.
In summary, clone 48908 contained only VRC. Clones
182424 (breast), 593023 (pancreas) and 36952 (infant brain)
contain VRA, VRB and VRC and correspond to the larger
isoform DTNB-1 of 71 kDa (GenBank accession number
Y15722). Clone 1187400 (prostate) contains VRB and does
not display VRC. All these results are summarized in Fig. 1.
A human adult skeletal muscle cDNA library was screened
with clone 48908. One clone, skm 19.1, was isolated and en-
tirely sequenced. This cDNA clone was revealed to contain
the full-length cDNA sequence and to include the VRA region
FEBS 19864 19-3-98 ^ Pagina 8 Cyaan Magenta Geel Zwart
A.A. Puca et al./FEBS Letters 425 (1998) 7^138
with a di¡erent C-terminus, resulting in a smaller isoform
(DTN-B2) similar to DTN-3 [19]. At amino acid 525 of skm
19.1, the sequence diverges from clone 48908 and after 97
nucleotides a TGA stop codon occurs resulting in a predicted
protein product of 559 aa. 3P RACE experiments on skm
cDNA using primers TO2865 and VR2 were performed. Se-
quence analysis of the derived products con¢rmed the results
obtained by analysis of the skeletal muscle cDNA. Further-
more, an additional EST clone (1268910 from human tonsil
cells) recently deposited in the dbEST database was shown to
contain the same 3P end displayed in the skm 19.1 cDNA
clone.
In order to determine the genomic structure of the 3P ends
of the DTN-B1 and DTN-B2 genes, we carried out PCR
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Fig. 2. Northern blot analysis of the DTN-B gene. Poly(A) RNA from multiple adult and fetal tissues was hybridized to a probe correspond-
ing to the 3P UTR of the DTN-B gene. A 1 kbp band was observed in heart and skeletal muscle, as well as a ubiquitously expressed 2.4 kbp
band, and a 4.4 kbp band detected only in heart and skeletal muscle (left panel). In fetal tissues only the 2.4 kbp band was observed in all
lanes (right panel).
Fig. 1. Schematic representation of the di¡erent isoforms identi¢ed for DTN-B; all of the oligonucleotides used for RT-PCR and RACE ex-
periments are indicated in A. DTN-B1 (A and B, top) corresponds to the longer isoform characterized and contains all three identi¢ed variable
regions (VRA, VRB, VRC). DTN-B2 (A, bottom and B) corresponds to the isoform displaying VRA and an alternative 3P end (gray), the pri-
mer VR2 used to perform RACE 3P experiments is indicated (A, bottom). Primers RH5P and RH3P used for the radiation hybrid mapping and
screening of the YAC libraries are indicated. DTN-B2 (A and B, bottom) corresponds to the shorter isoform.
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analysis on genomic DNA using primer pairs Ex20A/VRBR,
TO4094/VRCR, and VRCF/TO8080 (Fig. 1A). VRCF/
TO8080 failed to amplify genomic DNA. Sequence analysis
of the ampli¢cation products obtained with the ¢rst Ex20A/
VRBR and TO4094/VRCR primer pairs revealed the presence
of intron/exon boundaries at position 1735 and 1825 of the
DTN-B1 sequence, thus demonstrating that the variable re-
gions B and C represent alternatively spliced exons.
Primer pair TO3342/VR23PUTR, located across the alter-
native 3P sequence of DTN-B2, ampli¢ed an 8 kbp band on
genomic DNA. Sequence analysis of the product revealed the
presence of a splice site junction at position 1564 of DTN2-B2
cDNA.
3.3. Northern analysis
Commercial Northern blots of human poly(A) mRNA
from adult (heart, brain, placenta, lung, liver, skeletal muscle,
kidney, and pancreas) and fetal tissues (brain, lung, liver, and
kidney) were hybridized with a probe corresponding to the 3P
UTR of DTN-B1. Analysis under high stringency revealed in
adult tissues the presence of a 1 kbp band in heart and skel-
etal muscle, a 1.2 kbp band in placenta, a ubiquitously ex-
pressed 2.4 kbp band, and a fainter 4.4 kbp band detected
only in heart and skeletal muscle (Fig. 2, left panel). The 4.4
kb band speci¢c for muscle was con¢rmed on di¡erent North-
ern blots after longer exposure (data not shown). In fetal
tissues, only the 2.4 kbp band was observed in all lanes
(Fig. 2, right panel). The di¡erently sized bands observed
might be due to the extensive alternatively spliced forms ob-
served in these proteins. The same expression pattern was
obtained using the entire coding region as probe (data not
shown).
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Fig. 3. Alignment of the DTN and DTN-B proteins. The homology between the two proteins is very high, as shown by the vertical lines corre-
sponding to identical amino acids. The amino acids de¢ned by the dots are conserved changes. The following domains are recognized in both
proteins: an EF-hand motif (solid line); a putative zinc ¢nger ZZ domain (dashed line); a syntrophin binding site (box); the two helices of the
coiled-coil domain (italics); and the MA0 epitope (bold).
Fig. 4. Deletional analysis of the MA0 epitope and Western blot
analysis of human skeletal muscle homogenate. GST corresponds to
the vector alone; lane 1: GST-DTN-B (aa 12^346); lane 2: GST-
DTN-B (aa 95^597); lane 3: GST-DTN-B (aa 465^574); lane 4:
GST-DTN-B (aa 465^537); lane 5: GST-DTN-B (aa 465^505). As
shown, the MA0 epitope encompasses the region of aa 465^505.
SKM: human skeletal muscle homogenate after 1 min (left panel)
and 1 h (right panel) exposure.
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3.4. Sequence analysis of the DTN-B predicted protein product
BLAST-X, BLAST-P and BLAST-N analyses against the
public databases con¢rmed the homology of DTN-B with
dystrophin, dystrobrevins, Torpedo 87 kDa and the partial
rabbit A0 sequence. In detail, Best¢t analysis revealed 98%
similarity and 96% identity between the partial rabbit A0
sequence and DTN-B1. Homology between the DTN-B1
and DTN human proteins (isoform DTN1, GenBank acces-
sion number U46744) is 82.6% similarity and 76.7% identity.
The homology between rabbit A0 and the human DTN is
lower than between A0 and DTN-B. These data suggest that
DTN-B is more closely related to rabbit A0 than DTN.
Analysis of the DTN-B1 predicted protein product shows
an EF-hand motif (aa 113^171) that potentially binds calcium,
a putative zinc ¢nger (ZZ) domain (aa 237^286), a syntrophin
binding site (aa 399^448) and a coiled-coil motif (aa 425^517).
All of these domains are also present in the DTN predicted
protein product (Fig. 3). Recently, Sadoulet et al. demon-
strated that in DTN the site which binds to dystrophin cor-
responds to the ¢rst ¢ve heptad repeats of the coiled-coil
domain [12]. As shown in Fig. 3, the region encompassing
the coil-coiled domain is very similar between the DTN and
the DTN-B proteins, suggesting that this could also be the site
of interaction with dystrophin for DTN-B.
3.5. Immunoblot analysis of the DTN-B protein and human
skeletal muscle homogenate with the MA0 monoclonal
antibody
Immunoblot analysis of glutathione S-transferase (GST)
fusion proteins corresponding to di¡erent regions of the
DTN-B1 protein and of fresh homogenate of human muscle
was performed with the MA0 monoclonal antibody [9]. As
shown in Fig. 4, MA0 reacts with the extracts in lane 2 (aa
95^597), lane 3 (aa 465^574), lane 4 (aa 465^537), and lane 5
(aa 465^505), while it does not react with the extracts in lane 1
(aa 12^346) and with the vector alone (GST). This deletion
analysis indicates that the smaller portion of the protein rec-
ognized by MA0 is aa 465^505. This region encompasses a
portion of the coiled-coil domain and is 100% identical to
DTN (Fig. 3). Therefore, MA0 cannot distinguish between
DTN and DTN-B. In human skeletal muscle homogenate
(SKM), the MA0 antibody recognized two bands of 94 and
62 kDa after short exposure (1 min) (SKM, Fig. 4, left panel).
The same Western blot exposed for 1 h (Fig. 4, right panel)
revealed di¡erently sized bands, suggesting that this antibody
recognizes di¡erent isoforms belonging to both the DTN and
DTN-B proteins, or to additional dystrophin associated pro-
teins not yet identi¢ed. However, no additional sequences
were retrieved in the dbEST database using the amino acid
sequence recognized by MA0 as a query.
3.6. Expression of dystrobrevins in normal controls, DMD
carriers and DMD patients
Immunohistochemical staining of frozen sections from hu-
man quadriceps was performed using the MA0 antibody. As
shown in Fig. 5, MA0 immunostained muscle ¢ber sections
from normal controls at the sarcolemma (Fig. 5A, control). In
sections from DMD patients, no immunolabelling was de-
tected (Fig. 5A, DMD) and in DMD carriers not all ¢bers
were immunostained (Fig. 5A, carrier). The same experiments
were performed with dystrophin antibody and a similar label-
ling pattern was obtained (Fig. 5B). No cytoplasmic staining
was observed in any of the biopsies studied.
3.7. FISH, YAC and RH mapping in human, and genetic
mapping in the mouse
Clone 48908 was used as a probe for FISH mapping experi-
ments and was mapped to human 2p23. Oligonucleotides
(RH3P^RH5P), designed from the DTN-B consensus sequence
in order to amplify genomic DNA (Fig. 1A), were used to
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Fig. 5. Immunohistochemical study in muscle biopsies from normal controls, DMD carriers and DMD patients. In row A, the tissue specimens
were stained with MA0 monoclonal antibody and visualized with biotynilated anti-mouse IgG. In comparison, in row B an antibody speci¢c
for the dystrophin C-terminus was used on the same sections. The same pattern is observed with the two antibodies; in both cases the immu-
noreactivity is concentrated at the sarcolemma of healthy ¢ber from normal controls and DMD carriers, while expression is absent in a¡ected
muscle ¢bers from DMD patients and carriers.
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screen the YAC libraries available at the YAC Screening Cen-
ter, San Ra¡aele Biomedical Science Park, and the radiation
hybrid panel (Genebridge 4, Research Genetics). One clone,
YAC 783G10, containing the markers D2S171 and WI-6305,
and known to map on the 2p23 region, was identi¢ed. RH
screening con¢rmed that the gene is linked to the 2p23 region
(16.84 cR from WI-3742). Linkage mapping of the mDTN-B
was carried out in BSS backcross from the Jackson laborato-
ries [20]. This analysis mapped the mouse DTN-B transcript
to the proximal region of mouse chromosome 12 and co-seg-
regates with the marker D12mit37, in a region syntenic to
human chromosome 2 (data not shown).
4. Discussion
Dystrobrevins are part of the cytoplasmic subcomplex of
the DAPs. Using a bioinformatics approach we have identi-
¢ed a novel member of the dystrobrevin gene family, which
we named DTN-B. The previously reported DTN has been
postulated to be the human homolog of A0 [10]. A0 is a 94
kDa protein isolated in rabbit using a biochemical approach.
This protein is recognized by a monoclonal antibody, MA0,
obtained by immunizing the mouse with the DAP complex [9]
Sequence analysis revealed that DTN-B is more closely re-
lated to the rabbit A0 sequence than DTN. This data may
suggest that DTN-B corresponds to the human homolog of
rabbit A0, although further characterization of the human
DTN-B protein, together with a complete characterization
of the rabbit A0 full-length cDNA, is necessary to be conclu-
sive.
DTN and DTN-B share the same domains: an EF-hand
motif, a putative zinc ¢nger ZZ, a coiled-coil domain, and a
syntrophin binding site. In addition to these motifs, the DTN
protein presents a tyrosine kinase substrate domain which is
also present in Torpedo 87 kDa where it is believed to play a
role in the clustering of the nAChR [8]. Dystrophin and DTN
have been recently shown to interact in vitro through the ¢rst
heptad repeat in the coil-coiled domain [12]. In the same re-
gion, the homology between DTN and DTN-B is very high
(Fig. 3) (21/25 amino acids are identical), suggesting that
DTN-B could also interact with dystrophin through the
same binding site.
Western blot analysis was carried out with the MA0 anti-
body on skeletal muscle. The results partially overlap with
what was described in mouse using Ab 308 and Ab 433,
two antibodies produced using synthetic peptides correspond-
ing to residues 308^328 (Ab 308) and 433^451 (Ab 433) of the
murine DTN protein [11]. Alignment of murine DTN and
mDTN-B protein sequences shows that 6/21 aa of Ab 308
peptide and 19/19 aa of Ab 433 peptide are identical. Our
immunoblot analysis indicates that MA0 recognizes a ladder
of bands in skeletal muscle. In particular, a 94 kDa band was
observed. A similarly sized band was also detected in the same
mouse tissue using Ab 433 [11]. This band, which had not
been observed with di¡erent dystrobrevin antibodies, includ-
ing Ab 308, was believed not to correspond to a dystrobrevin
isoform. Our data indicate that the 94 kDa band can be de-
tected with an antibody (MA0) which, like Ab 433, recognizes
both DTN and DTN-B. Moreover, the fact that Ab 308,
which is speci¢c for DTN, does not recognize this larger
band indicates that the 94 kDa band corresponds either to a
larger DTN-B isoform not yet identi¢ed or to a new dystro-
brevin protein. Furthermore, our deletion analysis showed
that MA0 has a di¡erent epitope when compared to Ab
433, suggesting that the 94 kDa band recognized by both
antibodies is very unlikely to correspond to an aspeci¢c prod-
uct, but in our opinion corresponds to a dystrobrevin related
protein. This dystrobrevin related protein could explain the
larger murine isoform and the 4.4 kbp band observed in hu-
man muscles on Northern blot, for which we were unable to
identify a corresponding cDNA.
In normal individuals, dystrophin and associated proteins
have been shown to be located at the muscle membrane [21].
Several groups have also shown that in DMD patients, both
dystrophin and DAP immunoreactivity of muscle sarcolemma
was either absent or reduced [22]. In muscle of DMD carriers,
both healthy and a¡ected ¢bers (mosaicism) are present, and
this situation is re£ected by the dystrophin and DAP immu-
nostaining [23].
Immunostaining analysis on muscle ¢bers from controls,
DMD carriers and patients shows that MA0 recognized pro-
teins have a sarcolemma localization and that the sarcolem-
mal immunostaining is absent in dystrophic muscle ¢bers.
Since MA0 recognizes both the DTN and the DTN-B pro-
teins, the absence of detectable signal in DMD muscle ¢bers
suggests that DTN-B is a dystrophin associated protein,
although these results should be reproduced by using a
DTN-B speci¢c antibody to be conclusive.
The DTN-B gene was mapped to human 2p23 and to the
mouse chromosome 12 syntenic region, further supporting
that they are true orthologs and not just homologous genes.
No obvious candidate diseases that map to these regions
could be recognized. This of course does not exclude the pos-
sible involvement of DTN-B in the pathogenesis of genetic
disorders. Functional studies will elucidate the possible role
of DTN-B in the physiology of muscle and in muscular dys-
trophies.
5. Note added in proof
During the review process of this paper, Peters et al. re-
ported the isolation of the same transcript named L-dystro-
brevin in human (Peters et al. (1997) J. Biol. Chem. 272,
31561^31569), while Blake et al. reported the isolation of
the L-dystrobrevin mouse homolog (Blake et al. (1998) Proc.
Natl. Acad. Sci. USA 95, 241^246).
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